Nicotine in therapeutic angiogenesis and vasculogenesis
US7598275B2 · kind B2 · utility
15Cited by
24References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2006 |
| Grant date | Oct 6, 2009 |
| Priority date | — |
| Expiry date | Apr 18, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/446
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided for induction of angiogenesis by administration of nicotine or other nicotine receptor agonist. Induction of angiogenesis by the methods of the invention can be used in therapeutic angiogenesis in, for example, treatment of ischemic syndromes such as coronary or peripheral arterial disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.